StonvexLoading…
StonvexStonvexStonvexCore line items from NMRK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $718.06M | $2.77B | $1.91B | $1.20B |
Operating Income | $26.96M | $234.00M | $110.39M | $25.22M |
Net Income | $14.42M | $126.19M | $58.21M | $12.05M |
EPS (Diluted) | $0.08 | $0.68 | $0.32 | $0.06 |
Total Assets | $5.28B | $5.02B | $5.46B | $5.39B |
Total Liabilities | $3.59B | $3.27B | $3.83B | $3.86B |
Cash & Equivalents | $212.07M | $229.11M | $224.09M | $195.83M |
Free Cash Flow OCF − CapEx | $-257.81M | $142.63M | $-466.19M | $-571.09M |
Shares Outstanding | 256.04M | 253.45M | 253.18M | 253.67M |